UCLA High-Throughput Neuropsychiatric Disorder Phenotyping Center (UCLA HT-NPC)
加州大学洛杉矶分校高通量神经精神疾病表型中心 (UCLA HT-NPC)
基本信息
- 批准号:10643541
- 负责人:
- 金额:$ 165.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAllelesAnatomyArchitectureAstrocytesBiologicalBiological AssayBiological TestingBrainCRISPR/Cas technologyCalciumCell LineCell SurvivalCellsCerebrumClustered Regularly Interspaced Short Palindromic RepeatsCoculture TechniquesCommunitiesCore FacilityCoupledCustomDataDefectDevelopmentDevelopmental Delay DisordersDideoxy Chain Termination DNA SequencingDiseaseDisease PathwayEssential GenesFemaleGene ExpressionGenesGenetic HeterogeneityGenetic studyGenome engineeringHumanHuman GeneticsImageIn VitroIntellectual functioning disabilityKnock-outLinkMeasuresMethodsModelingMolecularMorphologyMutationNervous SystemNeurobiologyNeurodevelopmental DisorderNeuronsNeurophysiology - biologic functionNuclear RNAOpticsOrganoidsPathway interactionsPhenotypePhysiologicalProcessProductionProliferatingProteinsReproducibilityResearch PersonnelResolutionResource SharingRoleSchizophreniaSmall Nuclear RNASynapsesSystemTestingTimeautism spectrum disordercell typedata sharingdensitydisease phenotypedisorder riskengineered stem cellsexcitatory neurongene functiongenetic manipulationgenetic risk factorhigh dimensionalityhuman diseasehuman embryonic stem cellhuman modelhuman pluripotent stem cellhuman stem cellsin vivoinduced pluripotent stem cellinhibitory neuronknockout genemalemodel organismmolecular phenotypemultimodalitynerve stem cellneuralneurite growthneurodevelopmentneurogenesisneuronal cell bodyneuropsychiatric disordernovelnull mutationphenotypic datarisk variantscreeningsensorsexsingle nucleus RNA-sequencingsingle-cell RNA sequencingsmall hairpin RNAstem cell modelstem cellsthree dimensional cell culturethree-dimensional modelingtranscriptome sequencingvoltage
项目摘要
Project Summary/Abstract
Human genetic studies have identified hundreds of genes contributing to Neuropsychiatric and Neurodevelop-
mental Disease (NPD) risk. But for most genes, their normal function or the consequences of their absence or
reduction on neurodevelopment and neural function are not known. Here, we propose to address the substantial
challenges of discerning potential functions of hundreds of NPD genes through the development of a High
Throughput Neuropsychiatric Disease Phenotyping Center (UCLA HT-NPC), driven by the activity of 9 highly
collaborative investigators (Aharoni, Bhaduri, Damoiseaux, Geschwind, Golshani, Kitai, Luo, Novich, and Wells)
and two substantial core facilities (UCLA Molecular Screening Shared Resource and the Human Stem Cell and
Genome Engineering Center). Through a tiered approach, we combine high throughput and high value,
quantitative phenotyping with stem cell engineering to characterize the functional consequences of NPD gene
knockouts (null alleles), a key initial step that will inform our understanding of disease pathways. In the first step,
we will rapidly generate null alleles for 250 genes chosen by the Consortium using a rapid, high throughput
lentiviral based system in hESCs. Viability and neural induction potential will be assessed, and quantitative
phenotyping conducted using RNA-seq on all lines. Those genes passing viability and neural induction tests will
be used in the production of clonal null hiPSC lines (male and female) for downstream phenotyping and wider
distribution to the community. Subsequently, we will perform high throughput, quantitative, multi-scale
phenotyping at the molecular, morphological, and physiological levels in both 2D and 3D hiPSC-based models
of human cortical development. We leverage the relative strengths and scalability of each model to enable us to
perform both snRNA and bulk RNA-seq, measure the maturation, morphology, and synaptic density of neural
cells using automated imaging, including the multiplexed, protein-based CODEX (Phenocycler) platform, and
characterize neuronal activity and synchronization through optical recordings using custom-built mini-scope
arrays (STIMscope). By using multiple systems (e.g. hESC/hiPSC; gene editing, 2D and 3D cultures), we test
biological reproducibility across systems and technical reproducibility through replication. The use of
experimentally validated, quantitative phenotypes across multiple scales of analysis facilitates data sharing and
comparisons with other SSPsyGene investigators and provides a template for the field more broadly.
项目概要/摘要
人类遗传学研究已经确定了数百个与神经精神和神经发育有关的基因
精神疾病(NPD)风险。但对于大多数基因来说,它们的正常功能或它们缺失或缺失的后果
对神经发育和神经功能的减少尚不清楚。在此,我们建议解决实质性问题
通过开发高水平的方法来识别数百个 NPD 基因的潜在功能的挑战
吞吐量神经精神疾病表型中心 (UCLA HT-NPC),由 9 个高度活跃的活动驱动
合作研究人员(Aharoni、Bhaduri、Damoiseaux、Geschwind、Golshani、Kitai、Luo、Novich 和 Wells)
和两个重要的核心设施(加州大学洛杉矶分校分子筛选共享资源和人类干细胞和
基因组工程中心)。通过分层方法,我们将高吞吐量和高价值结合起来,
通过干细胞工程进行定量表型分析来表征 NPD 基因的功能后果
敲除(无效等位基因),这是一个关键的初始步骤,它将帮助我们了解疾病途径。在第一步中,
我们将使用快速、高通量的方法快速为联盟选择的 250 个基因生成无效等位基因
hESC 中基于慢病毒的系统。将评估活力和神经诱导潜力,并定量
使用 RNA-seq 对所有品系进行表型分析。那些通过活力和神经诱导测试的基因将
用于生产无克隆 hiPSC 系(雄性和雌性),用于下游表型分析和更广泛的研究
分发给社区。后续我们将进行高通量、定量、多尺度
在基于 hiPSC 的 2D 和 3D 模型中进行分子、形态和生理水平的表型分析
人类皮质发育。我们利用每个模型的相对优势和可扩展性,使我们能够
执行 snRNA 和bulk RNA-seq,测量神经的成熟度、形态和突触密度
使用自动成像的细胞,包括多重、基于蛋白质的 CODEX (Phenocycler) 平台,以及
使用定制的微型显微镜通过光学记录来表征神经元活动和同步
阵列(STIMscope)。通过使用多个系统(例如 hESC/hiPSC;基因编辑、2D 和 3D 培养),我们测试
跨系统的生物再现性和通过复制的技术再现性。使用
经过实验验证的跨多个分析尺度的定量表型有助于数据共享和
与其他 SSPsyGene 研究人员进行比较,并为该领域提供更广泛的模板。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL H GESCHWIND其他文献
DANIEL H GESCHWIND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL H GESCHWIND', 18)}}的其他基金
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
项目 2:H1/H2 单倍型对 FTD 引起的 MAPT 突变驱动的细胞疾病相关表型的影响
- 批准号:
10834336 - 财政年份:2023
- 资助金额:
$ 165.22万 - 项目类别:
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP
揭示染色体 17q21.31 Tau 单倍型对 FTD 和 PSP 神经变性风险的遗传机制
- 批准号:
10789246 - 财政年份:2023
- 资助金额:
$ 165.22万 - 项目类别:
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
揭示染色体 17q21.31 Tau 单倍型对 FTD 和 PSP 神经变性风险的遗传机制
- 批准号:
10902613 - 财政年份:2021
- 资助金额:
$ 165.22万 - 项目类别:
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
项目 2:H1/H2 单倍型对 FTD 引起的 MAPT 突变驱动的细胞疾病相关表型的影响
- 批准号:
10295518 - 财政年份:2021
- 资助金额:
$ 165.22万 - 项目类别:
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
揭示染色体 17q21.31 Tau 单倍型对 FTD 和 PSP 神经变性风险的遗传机制
- 批准号:
10295512 - 财政年份:2021
- 资助金额:
$ 165.22万 - 项目类别:
High-throughput Modeling of Autism Risk Genes using Zebrafish - DIVERSITY SUPPLEMENT
使用斑马鱼对自闭症风险基因进行高通量建模 - 多样性补充
- 批准号:
10818861 - 财政年份:2020
- 资助金额:
$ 165.22万 - 项目类别:
High-throughput modeling of autism risk genes using zebrafish
使用斑马鱼进行自闭症风险基因的高通量建模
- 批准号:
10264069 - 财政年份:2020
- 资助金额:
$ 165.22万 - 项目类别:
High-throughput modeling of autism risk genes using zebrafish
使用斑马鱼进行自闭症风险基因的高通量建模
- 批准号:
10478187 - 财政年份:2020
- 资助金额:
$ 165.22万 - 项目类别:
High-throughput modeling of autism risk genes using zebrafish
使用斑马鱼进行自闭症风险基因的高通量建模
- 批准号:
10121604 - 财政年份:2020
- 资助金额:
$ 165.22万 - 项目类别:
Genetic Investigation of Minimally Verbal Children with ASD
患有自闭症谱系障碍(ASD)的最少语言儿童的基因调查
- 批准号:
10689725 - 财政年份:2019
- 资助金额:
$ 165.22万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Role of POU4F1 in a Novel Form of Ataxia
POU4F1 在新型共济失调中的作用
- 批准号:
10741382 - 财政年份:2023
- 资助金额:
$ 165.22万 - 项目类别:
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
- 批准号:
10643269 - 财政年份:2023
- 资助金额:
$ 165.22万 - 项目类别:
Identifying and characterizing functional noncoding mutations in multiple myeloma
识别和表征多发性骨髓瘤的功能性非编码突变
- 批准号:
10586759 - 财政年份:2023
- 资助金额:
$ 165.22万 - 项目类别:
Contributions of autophagy-related genes in lupus
自噬相关基因在狼疮中的贡献
- 批准号:
10682136 - 财政年份:2023
- 资助金额:
$ 165.22万 - 项目类别:
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
项目 2:H1/H2 单倍型对 FTD 引起的 MAPT 突变驱动的细胞疾病相关表型的影响
- 批准号:
10834336 - 财政年份:2023
- 资助金额:
$ 165.22万 - 项目类别: